Home Weight loss (GLP-1) By state Indiana
Indiana GLP-1 Coverage: 3 Changes in 2026: 8 programs ship to IN
Indiana is in the middle of a GLP-1 shift. Medicaid announced in July 2026 that it will cover weight-loss GLP-1s through a federal program, state employees lost coverage in January, and a new law tightens compounding and med spas. The lowest price we found from a program that ships to Indiana: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Indiana at a glance
- Indiana Medicaid
- Does not cover for weight loss
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 37.5% (2025)
- Programs we compare that ship to IN
- 8 of 22
Good to know in Indiana: Indiana tightened its rules on compounded medications in 2026, including pharmaceutical-grade ingredients. The programs below say they serve Indiana.
Online GLP-1 programs for Indiana, cheapest first
Programs that ship to Indiana. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Indiana: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Indiana: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Three Indiana changes in one year
First, Medicaid. On July 30, 2026, Governor Braun directed FSSA to join the federal BALANCE model to cover select GLP-1s for eligible members with obesity. Drug makers agreed to a price of $245 per member per month, with Indiana paying about $85.16 of that. Eligibility and the start date had not been published when we checked. Until then, Medicaid members still pay on their own.
Second, state workers. The State Personnel Department ended weight-loss GLP-1 coverage on January 1, 2026. Diabetes treatment is a separate benefit. That hit a lot of households. State workers who were mid-treatment had to stop, switch to a self-pay plan, or ask their doctor about other options. Indiana is home to Eli Lilly, the maker of Zepbound and Foundayo, yet the state's own plan no longer pays for these drugs for weight loss. Maximus, one of the programs in our comparison, sells brand-name Zepbound online to Indiana addresses.
Third, compounding. SB 282 took effect July 1, 2026. It tightens rules for compounding from bulk drug substances and requires medical spas that dispense weight-loss drugs to register by January 1, 2027. For buyers, it means choosing a program that uses a properly licensed pharmacy matters more now. The programs on this page ship to Indiana. Compare their prices and plans below.
- Indiana announced on July 30, 2026 that Medicaid will join the federal BALANCE model to cover select GLP-1s for eligible members with obesity. (indianacapitalchronicle.com)
- Under Indiana's BALANCE deal, manufacturers supply select GLP-1s at $245 per member per month, with the state paying $85.16. (events.in.gov)
- Indiana's state employee plans ended weight-loss GLP-1 coverage on January 1, 2026. (in.gov)
- Indiana SB 282 (effective July 1, 2026) tightens compounding from bulk drug substances and requires med spas dispensing weight-loss drugs to register by January 1, 2027. (iga.in.gov)
- Indiana's adult obesity rate was 37.5% in 2025. (cdc.gov)
- Indiana's Statewide Uniform Preferred Drug List (effective December 1, 2025, for fee-for-service and managed care) states that under 405 IAC 5-24 Indiana Medicaid does not cover anorectics or any agent used to promote weight loss. (contenthub-aem.optumrx.com)
- IHCP bulletin BT202664 (April 30, 2026) announced Drug Utilization Review Board approval of revised prior authorization criteria for GLP-1 RA/GIP RA agents, effective for requests on or after July 1, 2026. (in.gov)
- Indiana's State Personnel Department says members using a GLP-1 for weight loss received a CVS Caremark letter, that the change doesn't mean they should stop their medication, and that full-price purchases outside the plan don't count toward the deductible or out-of-pocket maximum. (in.gov)
- State Medicaid agencies can join the federal BALANCE Model from May 2026 through January 1, 2027 (CMS). (cms.gov)
- KFF's table of 2025 CDC BRFSS results shows 13.4% of Indiana adults with a diabetes diagnosis, against 12.5% nationally. (kff.org)
Why Indiana Medicaid needed a federal deal to cover obesity drugs
Indiana's Medicaid drug coverage starts from a state rule, 405 IAC 5-24. It covers FDA-approved prescription drugs except a short list, and one item on that list is anorectics or any agent used to promote weight loss. The rule is printed on page one of the Statewide Uniform Preferred Drug List, which applies to fee-for-service members and every managed care plan.
That exclusion is why the July 2026 announcement mattered. Under the BALANCE model, federal officials negotiate GLP-1 prices with the drug makers for state Medicaid programs. States can start between May 2026 and January 1, 2027, and Indiana's deal set a price of $245 per member per month, with the state paying about $85.16 of it. Until the start date and eligibility rules are published, the exclusion still applies, so weight loss alone is not a covered use.
Watch the Indiana Health Coverage Programs bulletins. In April 2026 the state's Drug Utilization Review Board approved revised prior authorization criteria for GLP-1 and GIP drugs, effective for requests from July 1, 2026. Those criteria govern diabetes and other covered uses today. Watch the same bulletins for the obesity rules.
What Indiana state workers were told after the January cut
The State Personnel Department ended weight-loss GLP-1 coverage on January 1, 2026, across the three medical plans, which all use CVS Caremark for prescriptions. Members already taking a GLP-1 for weight loss got a letter from CVS Caremark about the change.
The department's advice was measured. It said the change does not mean you should stop your medication, and pointed members to their doctors for other covered options, naming phentermine and Xenical, which need a new prescription. It also warned that buying a GLP-1 at full price outside the plan does not count toward the deductible or the out-of-pocket maximum.
That last point matters if you are weighing cash options. Whatever you pay a self-pay program will sit outside your plan year, so compare programs on the total you'd spend over six or twelve months, not the first-month offer.
Indiana's numbers behind the debate
Indiana has one of the heaviest health burdens in the country. Only five states had a higher adult obesity rate than Indiana's 37.5% in the CDC's 2025 data. More than 13% of Hoosier adults have been diagnosed with diabetes, also above the national average.
That puts a lot of Hoosiers in the group the BALANCE coverage is meant for, and a lot of state workers in the group that just lost theirs. Commercial plans vary by employer. Self-funded employer plans follow federal rules, so for those the benefit is the employer's call, not the state's.
From Gary and South Bend to Bloomington and Evansville, online programs ship statewide. With SB 282 in force, ask any program where its medication is made and which pharmacy ships it to Indiana, and compare that answer along with the price.
GLP-1 in Indiana: questions
When will Indiana Medicaid start covering GLP-1s for weight loss?
The state announced on July 30, 2026 that it is joining the federal BALANCE model, but eligibility rules and a start date had not been published when we checked. Federal rules call for participating states to begin by January 1, 2027. If you do not want to wait, self-pay programs that ship to Indiana are listed above.
Do Indiana state employees still have GLP-1 coverage for weight loss?
No. Coverage of GLP-1s for weight loss under the State Personnel Department plans ended January 1, 2026. Diabetes treatment is handled separately. Many state workers now pay out of pocket through online programs. Compare their monthly prices in our table.
What does Indiana's SB 282 mean for compounded semaglutide?
SB 282, effective July 1, 2026, tightens how pharmacies compound from bulk ingredients and adds Board of Pharmacy enforcement. Med spas that dispense weight-loss drugs must register by January 1, 2027. Compounded GLP-1s are still sold, but the pharmacy behind your program matters more. Compare the programs above.
Can I buy brand-name Zepbound online in Indiana?
Yes. Maximus ships to Indiana and sells brand-name Zepbound after an online visit with a clinician, and it also offers the Foundayo pill. Maximus lists brand-name Zepbound from $449.99 a month. In November 2026 Maximus listed compounded tirzepatide from $99.99 a month on a 12-month plan, well below its brand-name Zepbound price. Compare both in our list.
Is there a GLP-1 program that serves Fort Wayne or Evansville?
Yes. Online programs ship to every Indiana city, not just Indianapolis. You complete a health form, a clinician licensed in Indiana reviews it, and medication arrives by mail. Ask how long shipping takes to your zip code. Compare price, follow-up support and dose options in our table above.
Does Indiana Medicaid cover Zepbound or Wegovy for weight loss right now?
Not yet. Indiana's Medicaid drug list excludes any agent used to promote weight loss under state rule 405 IAC 5-24. The state announced it will cover select GLP-1s for obesity through the BALANCE model, but the start date and eligibility had not been published when we checked. GLP-1s for diabetes follow separate prior authorization rules.
What did Indiana tell state employees to use instead of a GLP-1?
The State Personnel Department suggested asking a doctor about covered options such as phentermine or Xenical, which need a new prescription. It also said members don't have to stop a GLP-1 because of the change. Paying full price outside the plan doesn't count toward the deductible or out-of-pocket maximum.
Is a GLP-1 for weight loss covered by Indiana Medicaid managed care plans?
No. Indiana uses one statewide drug list for fee-for-service and all managed care plans, and it excludes weight-loss agents. So switching plans won't help. Coverage for obesity depends on the state's BALANCE launch. Until then, the self-pay programs on this page ship to Indiana.
When does the BALANCE sign-up window close for states like Indiana?
Federal officials say state Medicaid agencies can join the BALANCE model from May 2026 through January 1, 2027, and only at federal discretion after that. Indiana announced in July 2026 that it is joining. The exact start date and who qualifies had not been posted when we checked.
What is the cheapest GLP-1 in Indiana?
Compounded semaglutide from $89 a month at Lttl, which ships to Indiana. Tirzepatide starts at $99.99 a month.
See programs for Indiana All states
Sources: kff.org · cdc.gov · in.gov · iga.in.gov